The mean fold change mRNA levels of MYC in patients with DH-DLBCL and other MYC+ NHL were −3.45 (SD 0.68) and −2.61 (SD 0.54), respectively after C1D1 dose; and after C1D15 dose, MYC mRNA fold change was −3.38 (SD 1.07) and −1.97 (SD 0.75) for DH-DLBLC and other MYC+ NHL, respectively. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.